Literature DB >> 23255159

Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care.

Lillian Sung1, Theo Zaoutis, Nicole J Ullrich, Donna Johnston, Lee Dupuis, Elena Ladas.   

Abstract

In cancer control research, the objective is to reduce overall morbidity and mortality by decreasing acute and delayed treatment-related toxicities in all children with cancer. To date, the Children's Oncology Group (COG) has focused on infection, neurocognition, quality of life (QoL), and nutrition/antiemetics. COG is conducting randomized controlled trials (RCTs) to determine prophylaxis strategies that will reduce infections in high-risk populations. Two RCTs are determining if modafinil or computerized cognitive training improve cognitive functioning in pediatric brain tumor patients. QoL is being assessed in acute leukemia patients. Improved supportive care outcomes will only occur when the most effective interventions are established.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23255159      PMCID： PMC4447629          DOI： 10.1002/pbc.24426

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN： 1545-5009            Impact factor:   3.167


  27 in total

1.  Traumeel S in preventing and treating mucositis in young patients undergoing SCT: a report of the Children's Oncology Group.

Authors:  S F Sencer; T Zhou; L S Freedman; J A Ives; Z Chen; D Wall; M L Nieder; S A Grupp; L C Yu; I Sahdev; W B Jonas; J D Wallace; M Oberbaum
Journal:  Bone Marrow Transplant       Date:  2012-04-16       Impact factor: 5.483

2.  Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.

Authors:  Lillian Sung; Beverly J Lange; Robert B Gerbing; Todd A Alonzo; James Feusner
Journal:  Blood       Date:  2007-07-27       Impact factor: 22.113

3.  Perspectives toward oral mucositis prevention from parents and health care professionals in pediatric cancer.

Authors:  Marie-Chantal Ethier; Dean A Regier; Deborah Tomlinson; Peter Judd; John Doyle; Adam Gassas; Ahmed Naqvi; Lillian Sung
Journal:  Support Care Cancer       Date:  2011-09-25       Impact factor: 3.603

4.  Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?

Authors:  Sarah Alexander; Michael Nieder; Danielle M Zerr; Brian T Fisher; Christopher C Dvorak; Lillian Sung
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

5.  Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.

Authors:  M Fevzi Ozkaynak; Mark Krailo; Zhengjia Chen; James Feusner
Journal:  Pediatr Blood Cancer       Date:  2005-09       Impact factor: 3.167

6.  Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection.

Authors:  Lillian Sung; Paul C Nathan; Shabbir M H Alibhai; George A Tomlinson; Joseph Beyene
Journal:  Ann Intern Med       Date:  2007-09-18       Impact factor: 25.391

7.  Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.

Authors:  Adam Gassas; Ronald Grant; Susan Richardson; L Lee Dupuis; John Doyle; Upton Allen; Oussama Abla; Lillian Sung
Journal:  J Clin Oncol       Date:  2004-04-01       Impact factor: 44.544

8.  Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.

Authors:  H M Conklin; K R Krull; W E Reddick; D Pei; C Cheng; C H Pui
Journal:  J Natl Cancer Inst       Date:  2012-08-27       Impact factor: 13.506

9.  Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients.

Authors:  L Lee Dupuis; Sabrina Boodhan; Mark Holdsworth; Paula D Robinson; Richard Hain; Carol Portwine; Erin O'Shaughnessy; Lillian Sung
Journal:  Pediatr Blood Cancer       Date:  2013-03-19       Impact factor: 3.167

Review 10.  Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials.

Authors:  M C Ethier; M Science; J Beyene; M Briel; T Lehrnbecher; L Sung
Journal:  Br J Cancer       Date:  2012-05-08       Impact factor: 7.640
View more
  13 in total

1.  Muscle mass change during chemotherapy in children with high-risk neuroblastoma: a retrospective case series of 24 patients.

Authors:  Natsumi Nakamura; Kenji Kishimoto; Toshiaki Ishida; Sayaka Nakamura; Akihiro Tamura; Aiko Kozaki; Atsuro Saito; Daiichiro Hasegawa; Yoshiyuki Kosaka
Journal:  Eur J Pediatr       Date:  2021-05-10       Impact factor: 3.183

Review 2.  Systematic review and meta-analysis of objective and subjective quality of life among pediatric, adolescent, and young adult bone tumor survivors.

Authors:  Jamie Stokke; Lillian Sung; Abha Gupta; Antoinette Lindberg; Abby R Rosenberg
Journal:  Pediatr Blood Cancer       Date:  2015-03-27       Impact factor: 3.167

3.  The Children's Oncology Group: Organizational Structure, Membership, and Institutional Characteristics.

Authors:  Janice S Withycombe; Todd A Alonzo; Michele A Wilkins-Sanchez; Maxine Hetherington; Peter C Adamson; Wendy Landier
Journal:  J Pediatr Oncol Nurs       Date:  2018-11-14       Impact factor: 1.636

4.  Nutritional status and clinical outcomes in pediatric patients with solid tumors : A systematic review of the literature.

Authors:  Lenat Joffe; Sarah Dwyer; Julia L Glade Bender; A Lindsay Frazier; Elena J Ladas
Journal:  Semin Oncol       Date:  2018-12-21       Impact factor: 4.929

5.  Comparison of two chemotherapy-induced peripheral neuropathy measurement approaches in children.

Authors:  L S Gilchrist; L Marais; L Tanner
Journal:  Support Care Cancer       Date:  2013-09-27       Impact factor: 3.603

Review 6.  Nurse-Led Programs to Facilitate Enrollment to Children's Oncology Group Cancer Control Trials.

Authors:  Maureen Haugen; Katherine Patterson Kelly; Marcia Leonard; Denise Mills; Lillian Sung; Catriona Mowbray; Wendy Landier
Journal:  J Pediatr Oncol Nurs       Date:  2015-11-26       Impact factor: 1.636

7.  Normalized measures and patient characteristics to identify undernutrition in infants and young children treated for cancer.

Authors:  Daniel V Runco; Karen Wasilewski-Masker; Courtney E McCracken; Martha Wetzel; Claire M Mazewski; Briana C Patterson; Ann C Mertens
Journal:  Clin Nutr ESPEN       Date:  2020-06-02

8.  Facilitating accrual to cancer control and supportive care trials: the clinical research associate perspective.

Authors:  David Vanhoff; Tanya Hesser; Katherine Patterson Kelly; David Freyer; Susan Stork; Lillian Sung
Journal:  BMC Med Res Methodol       Date:  2013-12-31       Impact factor: 4.615

9.  The importance of evidence-based supportive care practice guidelines in childhood cancer-a plea for their development and implementation.

Authors:  E A H Loeffen; L C M Kremer; R L Mulder; A Font-Gonzalez; L L Dupuis; L Sung; P D Robinson; M D van de Wetering; W J E Tissing
Journal:  Support Care Cancer       Date:  2016-12-08       Impact factor: 3.603

10.  Features Associated With Weight Loss and Growth Stunting for Young Children During Cancer Therapy.

Authors:  Daniel V Runco; Karen Wasilewski-Masker; Claire M Mazewski; Briana C Patterson; Ann C Mertens
Journal:  J Pediatr Hematol Oncol       Date:  2021-11-01       Impact factor: 1.170
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.